Gastric dumping syndrome medical therapy

Gastric dumping syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Gastric dumping syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Gastric dumping syndrome medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Gastric dumping syndrome medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Gastric dumping syndrome medical therapy
CDC on Gastric dumping syndrome medical therapy
Gastric dumping syndrome medical therapy in the news
Blogs on Gastric dumping syndrome medical therapy
Directions to Hospitals Treating Gastric dumping syndrome
Risk calculators and risk factors for Gastric dumping syndrome medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Mainstay therapy for the management of dumping syndrome includes diet and pharmacological intervention.

Medical Therapy

Medical therapy for dumping syndrome includes diet and drug therapy.

Level of evidence	Type of evidence
I	Evidence from meta-analysis of multiple, well-designed, controlled studies (randomized trials with low false-positive and low false-negative errors)
II	Evidence from at least 1 well-designed, quasi-experimental study (randomized trials with high false-positive and high false-negative errors)
III	Evidence from well-designed, quasi-experimental studies (nonrandomized, controlled, single-group, pre–post, cohort and time or matched case–control series)
IV	Evidence from well-designed, non-experimental studies (comparative and correlational descriptive and case studies)
V	Evidence from case reports
Grade of recommendation	Level of evidence
A	Level I evidence or consistent findings from multiple studies (level II, III or IV)
B	Level II, III or IV evidence with generally consistent findings
C	Level II, III or IV evidence with inconsistent findings
D	Little or no systematic empirical evidence

Diet

Dietary Modifications (Level III; Grade B)

• Decrease carbohydrate intake
  • Avoid simple sugars like soda, candy sweets, and cookies
• Increase protein intake
• Increase fat intake
• Increase fiber intake
• Fluid restriction
• Dairy and dairy product restriction
• Shorter meals
• Lying supine for 30 minutes after a meal

Dietary Foods

The following is a table that illustrates the types of food to take and avoid in the case of dumping syndrome.

Breads, Cereals, Rice and Pasta	Foods To Choose	Foods to Avoid
6-11 servings each day One serving equals: 1 slice bread, 1 cup ready-to-eat cereal 1/2 cup cooked cereal, rice, or pasta	Breads, bagels, rolls, unsweetened cereals, pasta, potatoes, rice, crackers, and soup (only if taken one hour after solid foods at medium temperature).	Sweet rolls and doughnuts Sweetened cereals Pancakes and waffles with syrup Soup (taken with solid foods)
Fruits	Foods to Choose	Foods To Avoid
2-4 servings each day One serving equals: 1 medium size fresh, 1/2 cup canned, 3/4 cup juice	All fresh fruit Drained, unsweetened canned fruit Unsweetened frozen fruit 100 percent pure juice (taken one hour after meals)	Canned fruits in heavy syrup Sweetened frozen fruit Sweetened juice (that is, punch or sports drinks) Candied fruit
Milk and Dairy Products	Foods To Choose	Foods to Avoid
Limit to 2 servings each day One serving equals: 1 cup milk or yogurt	Plain or unsweetened yogurt Skim, 2 percent, or whole milk (taken one hour after meals)	Milkshakes and chocolate milk Sweetened yogurt
Meats, Poultry, Fish, Dry Beans, Peas, Eggs and Cheese	Foods to Choose	Foods to Avoid
2-3 servings or a total of six ounces daily One serving equals: 2-3 ounces cooked meat, chicken, or fish (about the size of a deck of cards) or 1/2 to 3/4 cup cottage cheese or tuna fish or one egg, 1/2 cup cooked beans, two tablespoons peanut butter, or one ounce of cheese. Choose leaner cuts of beef and meat and limit the amount of high-fat items like eggs and cheese.	All meat, fish, poultry, peanut butter, cheese, eggs, and dried beans or legumes	Any not tolerated
Vegetables	Foods to Choose	Foods to Avoid
3-5 servings each day One serving equals: 1 cup raw, 1/2 cup cooked or chopped.	All vegetables	Any not tolerated
Fats, Condiments and Beverages	Foods to Choose	Foods to Avoid
	All butter, margarine, cream, oil, and salad dressings Salt, herbs, spices, and condiments Any sugar-free beverage (coffee, tea, diet soda, etc., taken one hour after solids)	Sweet pickles or relish Sweetened drinks (regular lemonade, soda) Any others not tolerated
Snacks, Sweets, and Desserts	Foods to Choose	Foods to Avoid
	Sugar-free gelatin Sugar-free pudding Sugar-free candy Sugar substitutes	Sugar Candy and chocolate Cakes and cookies Ice cream and sherbet Honey, syrup, and jelly Sugar alcohols such as sorbitol, xylitol, and mannitol

 

Dietary Supplements (Level III; Grade C)

• Delay glucose absorption:
  • Pectin
  • Guar gum
  • Glucomannan

Drug Therapy

The two main stays for pharmacological intervention are Acarbose (Glucobay, Precose, Prandase) and Somatostatin analogues such as Octreotide (Sandostatin).

	Acarbose (Level III; Grade B)	Octreotide (Level II; Grade A)
Use	Late dumping syndrome	Early and Late dumping syndrome
Mechanism of Action	Inhibits carbohydrate absorption	Strong inhibitor of the gut hormones (especially insulin)
Dose	Rebound hypoglycemia: 25mg before breakfast, lunch and dinner Initiate effect: 50mg daily (QD) For complete resolution of symptoms: 50/100mg three times daily (TID). Especially beneficial in diabetics with dumping syndrome	Initiate effect: 25-50μg S.C two-three times daily (BID or TID) Maximum effect: 100-200μg S.C two-three times daily (BID or TID) Long-acting (New) I.M once monthly
Effect	Decrease postprandial hyperglycemia Decrease postprandial hypotention Decrease gastric emptying Increase Insulin secretion	Decrease symptoms Improves Sigstad's score Inhibits vasodilation Decrease Insulin levels Decrease gastric emptying Inhibits splanchnic vasoconstriction
Additional information	Limited to diarrhea severity Therapy role not yet clarified	Good for long-term refractory dumping syndrome Side effects are the reason for stopping long-term therapy. Treat this by giving an extra dose before sleeping or a pancreatic enzyme replacement. Short-acting improves symptoms New long-acting release is effective, increases weight and improves the quality of life Safe Last resort drug

Somatostatin analogues

• Pasireotide has a higher affinity than Octreotide and is more effective but it does not reduce dumping syndrome symptoms as well as Octreotide.
• Even though it has been safe and effective no results of its clinical trials have been published to date.

Drug	Dose	Effect
Tolbutamide	0.25-0.75 g, TID	Subjective improvement
Propranolol	10 mg, QID	Reduced early dumping
Cyproheptadine	4-8 mg, TID	Preventing vasomotor symptoms
Methysergide maleate	4-8 mg, TID	Reduced vasomotor symptoms
Verapamil	120-240 mg, QD	Reduced vasomotor symptoms
Acarbose	50-100 mg, TID	Reduced late dumping
Octreotide	25-100 mcg, TID	Reduced vasomotor symptoms
Pantoprazole (PPI)		Subjective improvement
Cholestyramine		Subjective improvement
Diazoxide	75-260 mg, QD	Subjective improvement
Nifedipine	30 mg, QD	Reduced hypoglycemic symptoms
Exendin 9-39	7500 pmol/kg prime	Reduced hypoglycemic symptoms

• Studies have documented decreased bioavailability for several drugs after RYGB surgery (eg, amoxicillin, azithromycin, cyclosporine A, levothyroxine, nitrofurantoin, mycophenolic acid, phenytoin, phenobarbital sirolimus, tacrolimus, tamoxifen). · Procedures that reduce the stomach size may increase mucosal toxicity of nonsteroidal anti-inflammatory drugs, salicylates, oral bisphosphonates, and oral iron tablet formulations. · Any procedure that causes dumping increases gut transit time and may decease drug absorption.

Pharmacologic intervention

Pharmacologic intervention plays an important role in the management of dumping syndrome in patients who fail to respond to dietary modification. Several studies have evaluated acarbose or somatostatin analogues in patients with dumping syndrome (described in detail below). The efficacy and tolerability of other pharmacologic agents have mainly been presented as case reports, and clinical evidence supporting their use in dumping syndrome is more limited.